LGC Capital Files Interim Financial Statements

Tuesday, March 12, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

MONTREAL, March 12, 2019 /PRNewswire/ -- LGC Capital Ltd. (the "Corporation" or "LGC") (TSXV: LG) announces

that it has filed its interim financial statements for the three-month period ended December 31, 2018, the accompanying management's discussion and analysis and the related CEO and CFO certifications (collectively, the "Interim Filings
").  The Interim Filings have been made through the SEDAR filing system.

Following the Interim Filings, the Corporation expects the management cease trade order issued by the Autorité des marches financiers in respect of LGC's Chief Executive Officer, Chief Financial Officer and directors, as previously announced, will be lifted in due course.

About LGC CapitalLGC is a leading cannabis investment firm with a focus on the Legal Global Cannabis market.  Through its growing portfolio investment companies, LGC is building a vertically integrated system of interconnected legal cannabis companies with cultivation, processing and distribution in Australia, Jamaica, Switzerland, Italy, and Canada serving domestic and export markets. LGC is a Canadian incorporated public company listed on the TSX Venture Exchange.

Through its partners and assuming pending transactions under review by the TSXV are approved, LGC presently will have interests in over 450,000 square feet of planted cannabis in Jamaica, Switzerland, Italy, and Australia. That is expected to increase to over 2,100,000 square feet by 2021, as its portfolio companies execute their expansion plans, in addition to the anticipated licensing of Tricho-Med's operations in Quebec, Canada.

LGC partners currently sell cannabis products in over 1,000 points of sale across Switzerland and Italy under the ONE Premium Cannabis and EasyJoint brands as well as medical cannabis oils in Australia under the Little Green Pharma brand. LGC's partners' branded products are available in a variety of formats including dry cannabis flower, tinctures, oils, seeds, and beverages.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information please contact: Chief Executive Officer, John McMullen, +1-416-803-0698, john@lgc-capital.com  Chief Financial Officer, Anthony Samaha, +44-20-7440-0640, anthony@lgc-capital.com  Investor Relations, Dave Burwell, +1-403-221-0915, dave@howardgroupinc.com

Cision View original content:http://www.prnewswire.com/news-releases/lgc-capital-files-interim-financial-statements-300810876.html

SOURCE LGC Capital Ltd.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store